Skip to main content

Table 1 Modulation of Gpr55 mRNA levels by receptor ligands

From: Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning

Condition

Modulator

Gpr55 mRNA levels (fold non-differentiated)

w/o

–

1.0***

+ RANKL

–

16.1 ± 1.6

 

 + 1 μM soybean LPI

24.5 ± 2.1**

 

 + 0.5 μM ML-191

46.1 ± 5.1***

 

 + 0.5 μM CBD

27.7 ± 0.5***

 

 + 30 μM O1918

15.8 ± 3.1

  1. RAW264.7 cells were treated without (w/o) or with 30 ng/mL RANKL for 72 h, in the absence or presence of the indicated GPR55 modulators
  2. Data are means ± SEM of at least three independent experiments. **p < 0.01; ***p < 0.005 versus RANKL alone (one-way ANOVA, followed by Fisher’s least significant difference tests)
  3. CBD cannabidiol